Additionally, they showed an increased NE/AAT ratio in the advanced stages of NAFLD with a good sensitivity and specificity to predict NASH (Zang et al. 2016). The gene discussed is SERPINA1; the disease is metabolic dysfunction-associated steatohepatitis.